This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1993 Oct;12(5):521-8.

doi: 10.1089/hyb.1993.12.521.

Antitumor antibodies for immunotherapy of ovarian carcinomas

U Wagner¹

Affiliations

PMID: 8300125
DOI: 10.1089/hyb.1993.12.521

Clinical Trial

Antitumor antibodies for immunotherapy of ovarian carcinomas

U Wagner. Hybridoma. 1993 Oct.

. 1993 Oct;12(5):521-8.

doi: 10.1089/hyb.1993.12.521.

Author

U Wagner¹

Affiliation

¹ Department of Gynecology and Obstetrics, University of Bonn, Germany.

PMID: 8300125
DOI: 10.1089/hyb.1993.12.521

No abstract available

PubMed Disclaimer

Similar articles

Immunotherapy of advanced ovarian carcinomas by activation of the idiotypic network.
Wagner UA, Oehr PF, Reinsberg J, Schmidt SC, Schlebusch HW, Schultes B, Werner A, Prietl G, Krebs D. Wagner UA, et al. Biotechnol Ther. 1992;3(1-2):81-9. Biotechnol Ther. 1992. PMID: 1305894
Ovarian carcinoma therapy with monoclonal antibodies.
Canevari S, Miotti S, Bottero F, Valota O, Colnaghi MI. Canevari S, et al. Hybridoma. 1993 Oct;12(5):501-7. doi: 10.1089/hyb.1993.12.501. Hybridoma. 1993. PMID: 8300122 Review. No abstract available.
Idiotypic cascades after MAb OC125 application.
Reinsberg J. Reinsberg J. Hybridoma. 1993 Oct;12(5):577-82. doi: 10.1089/hyb.1993.12.577. Hybridoma. 1993. PMID: 8300133 No abstract available.
[A trial with immunotherapy of ovarian cancer by idiotype vaccination. Activation of the idiotype network in patients with advanced ovarian cancers by treatment with monoclonal antibody OC125].
Wagner U, Reinsberg J, Krebs D. Wagner U, et al. Geburtshilfe Frauenheilkd. 1990 Oct;50(10):785-8. doi: 10.1055/s-2008-1026364. Geburtshilfe Frauenheilkd. 1990. PMID: 2286317 German.
[Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
Wagner U, Köhler S, Prietl G, Giffels P, Schmidt-Nicolai S, Schlebusch H, Grünn U, Bender H, Biersack HJ, De Potter C, Krebs D, Wallwiener D. Wagner U, et al. Zentralbl Gynakol. 1999;121(4):190-5. Zentralbl Gynakol. 1999. PMID: 10355096 Review. German.

See all similar articles

Cited by

Monoclonal antibodies in solid tumours: approaches to therapy with emphasis on gynaecological cancer.
Fleckenstein G, Osmers R, Puchta J. Fleckenstein G, et al. Med Oncol. 1998 Dec;15(4):212-21. doi: 10.1007/BF02787203. Med Oncol. 1998. PMID: 9951683 Review.
Antigen-specific active immunotherapy for ovarian cancer.
Paijens ST, Leffers N, Daemen T, Helfrich W, Boezen HM, Cohlen BJ, Melief CJ, de Bruyn M, Nijman HW. Paijens ST, et al. Cochrane Database Syst Rev. 2018 Sep 10;9(9):CD007287. doi: 10.1002/14651858.CD007287.pub4. Cochrane Database Syst Rev. 2018. PMID: 30199097 Free PMC article.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information